CDC declines to act on new flu vaccine mFlusiva, breaking longstanding practice

The CDC has taken no action on the new flu vaccine mFlusiva, a break from its longstanding practice of reviewing and recommending new flu vaccines, Fast Company reports. The agency's vaccine review-and-recommendation process has been upended over the past year.

Detected & updated continuously · Source: Nebula